Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal

Matthias Dominikus Hofer*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalFundamental and Clinical Pharmacology
Volume32
Issue number5
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this